These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 6761288)

  • 1. Three controlled trials of weight loss with phenylpropanolamine.
    Altschuler S; Conte A; Sebok M; Marlin RL; Winick C
    Int J Obes; 1982; 6(6):549-56. PubMed ID: 6761288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity.
    Arterburn D
    Clin Evid; 2003 Dec; (10):676-89. PubMed ID: 15555115
    [No Abstract]   [Full Text] [Related]  

  • 3. A double blind clinical evaluation of a phenylpropanolamine-caffeine-vitamine combination and a placebo in the treatment of exogenous obesity.
    Griboff SI; Berman R
    Curr Ther Res Clin Exp; 1975 Jun; 17(6):535-43. PubMed ID: 808376
    [No Abstract]   [Full Text] [Related]  

  • 4. Ephedrine as an anorectic: the story of the 'Elsinore pill'.
    Malchow-Møller A; Larsen S; Hey H; Stokholm KH; Juhl E; Quaade F
    Int J Obes; 1981; 5(2):183-7. PubMed ID: 7228474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity.
    Arterburn D
    Clin Evid; 2004 Jun; (11):762-76. PubMed ID: 15652036
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.
    Follows OJ
    Br J Clin Pract; 1971 May; 25(5):236-8. PubMed ID: 4931755
    [No Abstract]   [Full Text] [Related]  

  • 7. A double blind controlled trial of a new anorectic agent AN448.
    Woodhouse SP; Nye ER; Anderson K; Rawlings J
    N Z Med J; 1975 Jun; 81(542):546-9. PubMed ID: 1099491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of diethylpropion in the treatment of obese subjects.
    Cercato C; Roizenblatt VA; Leança CC; Segal A; Lopes Filho AP; Mancini MC; Halpern A
    Int J Obes (Lond); 2009 Aug; 33(8):857-65. PubMed ID: 19564877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethylpropion hydrochloride: an effective appetite suppressant.
    Bolding OT
    Curr Ther Res Clin Exp; 1974 Jan; 16(1):40-8. PubMed ID: 4203847
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical use of appetite suppressants.
    Silverstone T
    Drug Alcohol Depend; 1986 Jun; 17(2-3):151-67. PubMed ID: 3527636
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical studies with phenylpropanolamine: a metaanalysis.
    Greenway FL
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):203S-205S. PubMed ID: 1530830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
    Murphy JE; Donald JF; Molla AL; Crowder D
    J Int Med Res; 1975; 3(3):202-6. PubMed ID: 162676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diethylpropion and mazindol: An end to the discussion?
    Lucchetta RC; Riveros BS; Pontarolo R; Radominski RB; Otuki MF; Fernandez-Llimos F; Correr CJ
    Rev Assoc Med Bras (1992); 2017 Mar; 63(3):203-206. PubMed ID: 28489121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of phenylpropanolamine in the management of moderate obesity.
    Schteingart DE
    Int J Obes Relat Metab Disord; 1992 Jul; 16(7):487-93. PubMed ID: 1323545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of obesity: cost-benefit assessment of behavioral therapy, placebo, and two anorectic drugs.
    Dahms WT; Molitch ME; Bray GA; Greenway FL; Atkinson RL; Hamilton K
    Am J Clin Nutr; 1978 May; 31(5):774-8. PubMed ID: 417615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.
    Soto-Molina H; Pizarro-Castellanos M; Rosado-Pérez J; Rizzoli-Córdoba A; Lara-Padilla E; del Valle-Laisequilla CF; Reyes-García JG
    Int J Clin Pharmacol Ther; 2015 Jul; 53(7):541-9. PubMed ID: 26073353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind evaluation of long acting diethylpropion hydrochloride in obese patients from a general practice.
    Carney DE; Tweddell ED
    Med J Aust; 1975 Jan; 1(1):13-5. PubMed ID: 1092973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind clinical evaluation of the anorectic activity of phenylpropanolamine versus placebo.
    Greenway F
    Clin Ther; 1989; 11(5):584-9. PubMed ID: 2680083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release diethylpropion hydrochloride used in a program for weight reduction.
    Parsons WB
    Clin Ther; 1981; 3(5):329-35. PubMed ID: 7471128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What to tell patients about weight-loss methods. 2. Drugs.
    Friedman RB; Kindy P; Reinke JA
    Postgrad Med; 1982 Oct; 72(4):85-8. PubMed ID: 7122365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.